Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-class CpG oligodeoxynucleotide TLR9 agonist
Krieg, Arthur M, Efler, Susan M, Wittpoth, Michael, Al Adhami, Mohammed J, Davis, Heather L
Published in Journal of immunotherapy (1997) (01.11.2004)
Published in Journal of immunotherapy (1997) (01.11.2004)
Get more information
Journal Article
Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON™), an investigational synthetic Toll-like receptor 9 agonist
VICARI, Alain P, SCHMALBACH, Tess, LEKSTROM-HIMES, Julie, MORRIS, Mary Louise, AL-ADHAMI, Mohammed J, LAFRAMBOISE, Chantal, LEESE, Philip, KRIEG, Arthur M, EFLER, Susan M, DAVIS, Heather L
Published in Antiviral therapy (01.01.2007)
Published in Antiviral therapy (01.01.2007)
Get full text
Journal Article